Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1976 1
1977 1
1978 1
1980 3
1984 1
1986 2
1987 2
1988 1
1989 6
1990 2
1991 1
1992 5
1993 9
1994 3
1995 4
1996 9
1997 3
1998 6
1999 6
2000 7
2001 7
2002 13
2003 15
2004 6
2005 7
2006 9
2007 11
2008 10
2009 6
2010 13
2011 10
2012 9
2013 6
2014 8
2015 9
2016 5
2017 3
2018 1
2019 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Results by year

Filters applied: . Clear all
Page 1
Atypical cellular disorders.
Arceci RJ, Longley BJ, Emanuel PD. Arceci RJ, et al. Hematology Am Soc Hematol Educ Program. 2002:297-314. doi: 10.1182/asheducation-2002.1.297. Hematology Am Soc Hematol Educ Program. 2002. PMID: 12446429 Review.
Comments from the editor-in-chief.
Arceci RJ. Arceci RJ. J Pediatr Hematol Oncol. 2003 Feb;25(2):97-8. doi: 10.1097/00043426-200302000-00001. J Pediatr Hematol Oncol. 2003. PMID: 12571457 No abstract available.
Comments from the Editor-in-Chief.
Arceci RJ. Arceci RJ. J Pediatr Hematol Oncol. 1999 Jan-Feb;21(1):1-2. doi: 10.1097/00043426-199901000-00001. J Pediatr Hematol Oncol. 1999. PMID: 10029803 No abstract available.
Treatment options--commentary.
Arceci RJ. Arceci RJ. Br J Cancer Suppl. 1994 Sep;23:S58-60. Br J Cancer Suppl. 1994. PMID: 8075010 Free PMC article. Review.
Emerging cancer-targeted therapies.
Arceci RJ, Cripe TP. Arceci RJ, et al. Pediatr Clin North Am. 2002 Dec;49(6):1339-68, vii-viii. doi: 10.1016/s0031-3955(02)00096-2. Pediatr Clin North Am. 2002. PMID: 12580369 Review.
Congenital and neonatal leukemia.
Sande JE, Arceci RJ, Lampkin BC. Sande JE, et al. Among authors: arceci rj. Semin Perinatol. 1999 Aug;23(4):274-85. doi: 10.1016/s0146-0005(99)80036-6. Semin Perinatol. 1999. PMID: 10475541 Review.
Comments from the Editor-in-Chief.
Arceci RJ. Arceci RJ. J Pediatr Hematol Oncol. 2002 Dec;24(9):697-9. doi: 10.1097/00043426-200212000-00001. J Pediatr Hematol Oncol. 2002. PMID: 12468905 No abstract available.
Targeting cell cycle regulators in hematologic malignancies.
Aleem E, Arceci RJ. Aleem E, et al. Among authors: arceci rj. Front Cell Dev Biol. 2015 Apr 9;3:16. doi: 10.3389/fcell.2015.00016. eCollection 2015. Front Cell Dev Biol. 2015. PMID: 25914884 Free PMC article. Review.
208 results